Skip to content

Venture company Eight Roads organizing the fourth annual healthcare conference this year

Venture capital firm, Eight Roads Ventures, plans to convene the fourth annual healthcare conference, Scale-Up Health, featuring famous figures such as Varun Dua among the speakers.

Venture firm Eight Roads sets up the fourth installment of their yearly healthcare gathering.
Venture firm Eight Roads sets up the fourth installment of their yearly healthcare gathering.

Venture company Eight Roads organizing the fourth annual healthcare conference this year

The Scale-Up Health conference, scheduled for 10 September 2025 in Mumbai, is set to be a significant event in India's healthcare sector. Hosted by Eight Roads Ventures, this annual gathering aims to be a nexus for leaders to learn, network, and grow together, under the theme "India's Healthcare Decade - Innovation, Expansion & Global Influence."

Eight Roads Ventures, a global venture capital firm with a 50-year investment legacy, entered the Indian market in 2007 and has since backed over 30 companies across the healthcare and life sciences value chain. The firm's focus is on fostering innovation and growth, evident in their support of over 70 companies in their focus areas: healthcare and technology.

Scale-Up Health, conceived and championed by Eight Roads Ventures, has grown into a major forum attended by over 500 founders and experts united to advance healthcare innovation. Since its inception in 2022, the event has become a vital platform for innovation in India's healthcare sector.

The conference will feature a roster of distinguished speakers, including Rehan Khan (MSD India), Viren Shetty (Narayana Health), Varun Dua (Acko), Venky Ananth (Infosys), Srikanth Velamakanni (Fractal Analytics), Dr Harlan Krumholz (Yale University/Yale New Haven Health), Dr Arjun Surya (Curadev), Amit Mookim (Immuneel Therapeutics), Dr Sadhna Joglekar (Novartis), Dr Robert Weisskoff (F-Prime), and Priya Deshmukh (ICICI Lombard).

The event will spotlight advances redefining India's healthcare landscape, including swift market expansion, biotech innovation, and AI-driven care. It aims to catalyse industry growth by fostering strategic connections, sharing actionable insights, and providing a vibrant collaborative platform.

Dr Prem Pavoor, Managing Partner (India) at Eight Roads Ventures, stated that Scale-Up Health was launched as a catalyst for change and has become a vital platform for innovation in India's healthcare sector. Scale-Up Health is India's first community for healthcare and life sciences leaders.

Eight Roads manages over $11 billion in assets across offices in China, India, Japan, the United Kingdom, and the United States. More than 30 technology scale-ups in India are part of Eight Roads' portfolio. The collaboration with McKinsey & Company as knowledge partners underscores the conference's commitment to strategic industry insight and impact.

In India, Eight Roads' healthcare and life sciences portfolio spans the entire value chain, with an emphasis on early to growth-stage investments. The conference will gather India's leading healthcare and life sciences founders, as well as international experts, to discuss critical topics such as India’s path to its first billion-dollar drug, the evolution of value-based healthcare, biotech breakthroughs, and the role of AI and large language models (LLMs) in healthcare delivery.

The Scale-Up Health conference, therefore, stands as a testament to Eight Roads Ventures' commitment to driving innovation and change in India's healthcare sector. It serves as a platform for influential stakeholders to map and shape the country’s healthcare landscape for the next decade, making it a pivotal event in India's healthcare landscape.

Technology and innovation will be key focus areas at the Scale-Up Health conference, as over 70 of the companies supported by Eight Roads Ventures operate in these fields. The event aims to catalyze industry growth and provide a vibrant collaborative platform for advances redefining India's healthcare landscape, including AI-driven care and biotech innovation.

Read also:

    Latest